Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance

This publication has 19 references indexed in Scilit:

• 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
  JACC, 2014
• Muscle symptoms in statin users, associations with cytochrome P450, and membrane transporter inhibitor use: A subanalysis of the USAGE study
  Journal of Clinical Lipidology, 2014
• New Horizons in Lipid Management
  JACC, 2013
• Efficacy and Safety of a Novel Dual Modulator of Adenosine Triphosphate-Citrate Lyase and Adenosine Monophosphate-Activated Protein Kinase in Patients With Hypercholesterolemia
  JACC, 2013
• Treatment strategies in patients with statin intolerance: The Cleveland Clinic experience
  American Heart Journal, 2013
• Effect of Statins on Skeletal Muscle Function
  Circulation, 2013
• Efficacy and Tolerability of Fluvastatin XL 80 mg Alone, Ezetimibe Alone, and the Combination of Fluvastatin XL 80 mg With Ezetimibe in Patients With a History of Muscle-Related Side Effects With Other Statins
  The American Journal of Cardiology, 2008
• Differential Effect of Hypolipidemic Drugs on Lipoprotein-Associated Phospholipase A ₂
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2007
• Colesevelam Hydrochloride (Cholestagel)
  Archives of internal medicine (1960), 1999
• Effects of fenofibrate on plasma lipoproteins in hypercholesterolemia and combined hyperlipidemia
  The American Journal of Medicine, 1987